Start-Ups
Fine-Tuning Neurostimulation With Fasikl
On the heels of Fasikl’s successful TRANQUIL study, FDA approves its combination of sophisticated AI and non- to minimally invasive stimulation.
Welcome to MyStrategist, the digital home for MedTech Strategist.
MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest IssueStart a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
Investors & Dealmaking
The Digest: July 2025
In this month's news, 510(k)s for ENT devices, Zimmer Biomet buys Monogram, clearances for Tissium and Anaconda Biomed, and more.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
Business Strategies
The Women’s Brain Foundation: A New Model for Precision Development
The Women’s Brain Foundation is out to demonstrate that sex- and gender-specific precision medicine is not only cost-effective healthcare, it’s also a way to derisk both pharma and device therapy development, and not just for diseases that only affect women.